Recombinant Protein Market
Recombinant Protein Market Analysis By Product (Cytokines & Growth Factors, Antibodies), By Host Cell (Mammalian Systems, Yeast & Fungi, Bacterial Cells), By Application (Therapeutics, Research), By End Use, By Region - Global Market Insights 2022 to 2032
Analysis of Recombinant Proteins Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Recombinant Proteins Market Outlook (2022-2032)
The global recombinant proteins market size was valued at US$ 457.1 Million in 2022, and is projected to reach US$ 719.5 Million by 2032, growing at a CAGR (Compound Annual Growth Rate) of 4.6% during the forecast period from 2022 to 2032.
The market has contributed to 10% of the overall drug market. However, it is anticipated to capture large proportion over the forecast period.
Report Attributes |
Details |
|
Recombinant Proteins Market Size (2021A) |
US$ 437 Million |
|
Estimated Market Value (2022E) |
US$ 457.1 Million |
|
Forecasted Market Value (2032F) |
US$ 719.5 Million |
|
Global Market Growth Rate (2022-2032) |
4.6% CAGR |
|
North America Market Share (2021) |
~ 32.7% |
|
Europe Market Growth Rate (2022-2032) |
~ 4.4% CAGR |
|
United States Market Growth Rate (2022-2032) |
~ 5% CAGR |
|
Market Share of Top 5 Companies |
~ 31.1% |
|
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Sales Analysis of Recombinant Protein (2017-2021) Vs. Market Forecast Outlook (2022-2032)
Most human diseases are partly associated with the dysfunction of specific proteins. Thus, growing chronic diseases such as cancer, diabetes, anemia, etc., have created a path for the production of recombinant proteins. Also, augmenting focus on healthcare provides a space for innovation in biologics and biosimilars which also supports the invention in the recombinant proteins market in the past years.
Hence, the sale of recombinant protein has observed noticeable growth during the historical period representing a compound annual growth rate of 4.3%.
Furthermore, the demand for recombinant protein will observe an upward trend during the forecast period due to rising investment in R&D, and escalating demand for protein-based regenerative and therapeutic medicines around the globe.
Apart from healthcare, recombinant proteins are also used in agriculture, food production, and bioengineering which will further increase the demand in near future.
Fact.MR suggests that the global recombinant proteins market will be valued at US$ 719.5 Million by 2032 end posing a CAGR of 4.6% since 2022.
- Short Term (2022 Q2 to 2025): Growing cases of chronic diseases and unavoidable viral outbreaks will upsurge the demand for protein-based therapeutic treatments. This will upsurge the growth of the market during the short term forecast period.
- Medium Term (2025-2028): Rising awareness regarding the use of recombinant proteins in food production and agriculture sector will give momentum to the market growth in medium term forecast period.
- Long Term (2028-2032): The government spending on biotechnology for novel innovation and the production of recombinant proteins will provide long-term growth to the market.
Over the 2017-2021 historical period, the global recombinant proteins market registered a CAGR of 4.3%, and according to the Fact.MR, a market research and competitive intelligence provider, the market is projected to exhibit growth at 4.6% CAGR between 2022 and 2032.
Market share analysis of recombinant protein based on product type and region is provided in a nutshell in the above image. Under the product type segment, the growth factors sub-segment dominates with 21.3% market share in 2022.
What’s Driving Demand for Recombinant Protein?
“Evolving Generations of Recombinant Protein with Wide Applications Spur the Market Growth’’
Recombinant proteins are not only used in research but also used as a drug to treat various chronic diseases such as dwarfism, congestive heart failure, diabetes, cerebral apoplexy, myocardial infarction, multiple sclerosis, anemia, neutropenia, etc. There are almost more than 130 recombinant proteins that have been approved by US FDA to date. Though, more than 170 recombinant proteins are manufactured and are widely used in medicines across the world.
Moreover, recombinant protein generations came up with some improvements as compared to the previous generation. Such as first-generation recombinant proteins comprised of native structures of proteins, furthermore, the second generation encompassed proteins with enhanced properties such as specificity, biodistribution, and efficacy. Furthermore, the third generation of recombinant protein comprised new formulations and new routes of administration with higher efficacy and safety. Hence, product improvisation is the key contributor to the recombinant proteins market growth.
“Significant Rise of Research in Biologics led to Upsurge the Sale of Recombinant Proteins”
The wide growth of healthcare sector across the world supports the investment in research and development to introduce novel solutions for various diseases. The growth of recombinant proteins is directly proportional to the growth of healthcare sector and investment in biologics. Also, government funding led to amplifying the research activities in biotechnological businesses and academic institutes to bring innovations in recombinant proteins market.
The above-mentioned factors are anticipated to fuel the request for recombinant antibodies and recombinant human erythropoietin etc.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What Do Recombinant Protein Manufacturers Need to Watch Out for?
“Complexity of Protein, Its Purification and Protein Expression may Slowdown the Production”
The production of recombinant protein is a complex process owing to complex structure of a protein. For instance, the presence of GPI-anchor or transmembrane domains may mix the target proteins and plasma membranes, which reduces the yield of protein. In addition, the transmembrane is hydrophobic in nature which also disturbs the protein stability.
Additionally, aggregation and over-expression of the target protein may create unexpected physiological variations in the host cells which further results in making misfolded proteins as well as protein degradation by the enzyme protease of the host body.
Hence, process optimization and careful planning are the necessary factors in recombinant protein expression to create an appropriate host, culture duration, and condition. Thus, manufacturers need to watch out aforementioned factors to avoid hindrances in market growth.
Country-wise Insights
Will the High R&D Spending in United States Drive High Demand for Recombinant Protein?
The U.S. is anticipated to grow with a CAGR of 5% during the forecast period. The high growth of recombinant proteins market in U.S. is due to high spending on research and development, government support for innovations, and huge presence of key market players in that country.
Apart from this, the United States is a prominent country for prevalence of chronic diseases such as cancer and diabetes which makes it a noticeable country for innovations in recombinant proteins. Intensifying per capita healthcare spending is also a major factor in the growing acceptance of recombinant proteins in the U.S.
Why Recombinant Protein Market Expected to Be Highly Opportunistic in Japan?
Japan is the key contributor to the growth of the recombinant proteins market in the APAC region. The dominance is due to huge government support and the growing biotechnology industry in Japan. For instance, the government of Japan has financed Okinawa Health Biotechnology Research and Development Center, which offers free research amenities to capable biotechnology companies.
The manufacturers who are willing to invest in international markets, Japan, and Asian markets will provide incredible opportunities for collaborations and business developments.
Category-wise Insights
Which Product Type is Most Widely Used?
The recombinant protein under the product type segment is categorized into Immune checkpoint regulators, chemokines, growth factors, cytokines, colony-stimulating factors, hormones, enzymes & inhibitors, and others. Amongst them, the recombinant growth factors sub-segment holds the largest market share of 21.3% of the global market in 2021 and is expected to witness a CAGR of 4.5% during the forecast years of 2022-2032.
Recombinant growth factors have gained popularity in the market owing to their wide array of applications. Various recombinant growth factors have been verified for their capability to quicken chronic wound healing in diabetic patients. Apart from this, one of the prominent applications of recombinant growth factors in clinical nephrology. It acts as a growth hormone in children who suffer from growth failure with chronic renal failure. Hence, the wide applications of recombinant growth factors give them popularity among other recombinant proteins.
Which application is estimated to support marker growth in recombinant protein market during the forecast period?
In terms of applications, recombinant proteins are segmented into drug discovery & development, basic research, toxicity screening, biopharmaceutical production, drug screening, tissue engineering, and forensic testing. Which, the basic research segment holds the majority of the global recombinant proteins market share. It is anticipated to follow the same trend during the forecast period. The basic research segment is projected to hold 55.1% share of the market by 2032.
To clarify the fundamental and basic principle of an organism can be carried with the help of recombinant protein. They can be useful to locate and identify the location of protein determined by a specific gene and to reveal the role of other genes such as metabolism, replication, growth, translation, transcription, etc. Hence, due to the above-mentioned ability, recombinant proteins are widely used in cell biology, molecular biology, structural and biophysical studies, biochemistry, and several other research areas.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Competitive Landscape
Prominent recombinant protein manufacturers are A.M.S. Biotechnology (Europe) Limited, Bio-Rad Laboratories Inc., BPS Bioscience Inc., Abcam plc, PerkinElmer Inc., Crown Bioscience Inc., GenScript Corporation, Merck Millipore Limited, Sigma Aldrich Company Ltd., Novoprotein Scientific, PeproTech Inc., Thermo Fisher Scientific Inc.
Key market players are focusing on products to widen the applications of recombinant proteins in various industries by investing in R&D. Investment to bring novel products into the market is the key strategy among the market leaders. Apart from this, acquisitions, partnerships, and collaborations are some in-organic growth tactics that support maintaining their position in the market.
- In August 2022, Chinese biotechnology company Bao Pharmaceuticals reported that it had raised more than US$ 100 million in a Series B investment round. The company focuses on the commercialization of recombinant protein therapeutics and antibody drugs. The funding was meant to be used for the creation and marketing of medicines made from recombinant proteins. This round was won by Oriental Fortune Capital.
- In March 2020, AMS Biotechnology launched its recombinant protein for the detection of COVID-19 and related RNA viruses. The product launch helped the company to achieve high revenue during the pandemic period.
Fact.MR has provided detailed information about the price points of key manufacturers of recombinant protein positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.
Key Segments in Recombinant Protein Industry Research
-
By Product Type :
- Immune Checkpoint Regulators
- Chemokines
- Growth Factors
- Cytokines
- Colony Stimulating Factors
- Hormones
- Enzymes & Inhibitors
- Other
-
By End User :
- Biopharmaceutical Companies
- Contract Research Organizations (CROs)
- Academic & Research Institutes
- Forensic Science Laboratories
- Food & Beverage Companies
- Diagnostic Centers
- Others
-
By Application :
- Drug Discovery & Development
- Basic Research
- Toxicity Screening
- Biopharmaceutical Production
- Drug Screening
- Tissue Engineering
- Forensic Testing
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & ASEAN
- Oceania
- MEA
Table of Content
1. Recombinant Protein Market - Executive Summary 2. Market Overview 2.1. Market Definition and Introduction 2.2. Market Taxonomy/ Research Scope 3. Market Background and Foundation Data 3.1. Global Pharmaceutical Industry Growth 3.2. Global Healthcare Spending Analysis 3.3. Impact of Advancements in Biotechnology On Recombinant Protein Market 3.4. Recombinant Protein Usage Indication Analysis 3.4.1. By Region 3.4.2. By Key companies 3.5. Growth & Development Pattern in Recombinant Protein Market 3.6. Recombinant Protein Opportunity Assessment 3.6.1. Total Available Market (US$ Million) 3.6.2. Serviceable Addressable Market (US$ Million) 3.6.3. Serviceable Obtainable Market (US$ Million) 3.7. Market White Space Assessment 3.8. Market Dynamics 3.8.1. Market Growth Drivers 3.8.2. Market Restraints 3.8.3. Market Opportunity 3.8.4. Market Trends 3.9. Forecast and Macro-Economic Factors – Relevance and Impact 3.10. PESTLE Analysis 3.11. Porter’s Five Force Analysis 3.12. Investment Feasibility Analysis 3.13. Key Success Factors 4. Global Recombinant Protein Market Value (US$ Million) Analysis and Forecast 4.1. Historical Market Value (US$ Million) Analysis, 2017-2021 4.2. Current and Future Market Value (US$ Million) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Recombinant Protein Market Analysis and Forecast, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size (US$ Million) Analysis By Product Type, 2017-2021 5.3. Current and Future Market Size (US$ Million) Analysis Forecast By Product Type, 2022-2032 5.3.1. Immune Checkpoint Regulators 5.3.2. Chemokines 5.3.3. Growth Factors 5.3.4. Cytokines 5.3.5. Colony Stimulating Factors 5.3.6. Hormones 5.3.7. Enzymes & Inhibitors 5.3.8. Other 5.4. Market Attractiveness Analysis By Product Type 6. Global Recombinant Protein Market Analysis and Forecast, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size (US$ Million) Analysis By Application, 2017-2021 6.3. Current and Future Market Size (US$ Million) Analysis Forecast By Application, 2022-2032 6.3.1. Drug Discovery & Development 6.3.2. Basic Research 6.3.3. Toxicity Screening 6.3.4. Biopharmaceutical Production 6.3.5. Drug Screening 6.3.6. Tissue Engineering 6.3.7. Forensic Testing 6.4. Market Attractiveness Analysis By Application 7. Global Recombinant Protein Market Analysis and Forecast, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size (US$ Million) Analysis By End User, 2017-2021 7.3. Current and Future Market Size (US$ Million) Analysis Forecast By End User, 2022-2032 7.3.1. Biopharmaceutical Companies 7.3.2. Contract Research Organizations (CROs) 7.3.3. Academic & Research Institutes 7.3.4. Forensic Science Laboratories 7.3.5. Food & Beverage Companies 7.3.6. Diagnostic Centers 7.3.7. Others 7.4. Market Attractiveness Analysis By End User 8. Global Recombinant Protein Market Analysis and Forecast, By Region 8.1. Introduction 8.2. Historical Market Size (US$ Million) Analysis By Region, 2017-2021 8.3. Current Market Size (US$ Million) Analysis Forecast By Region, 2022-2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. East Asia 8.3.5. South Asia & ASEAN 8.3.6. Oceania 8.3.7. Middle East & Africa 8.4. Market Attractiveness Analysis By Region 9. North America Recombinant Protein Market Analysis and Forecast 9.1. Introduction / Key Findings 9.2. Pricing Analysis 9.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017-2021 9.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 - 2032 9.4.1. By Country 9.4.1.1. U.S. 9.4.1.2. Canada 9.4.2. By Product Type 9.4.3. By Application 9.4.4. By End User 9.5. Market Attractiveness Analysis 9.5.1. By Country 9.5.2. By Product Type 9.5.3. By Application 9.5.4. By End User 10. Latin America Recombinant Protein Market Analysis and Forecast 10.1. Introduction / Key Findings 10.2. Pricing Analysis 10.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017-2021 10.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 - 2032 10.4.1. By Country 10.4.1.1. Brazil 10.4.1.2. Mexico 10.4.1.3. Argentina 10.4.1.4. Rest of Latin America 10.4.2. By Product Type 10.4.3. By Application 10.4.4. By End User 10.5. Market Attractiveness Analysis 10.5.1. By Country 10.5.2. By Product Type 10.5.3. By Application 10.5.4. By End User 11. Europe Recombinant Protein Market Analysis and Forecast 11.1. Introduction / Key Findings 11.2. Pricing Analysis 11.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017-2021 11.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 - 2032 11.4.1. By Country 11.4.1.1. Germany 11.4.1.2. France 11.4.1.3. Italy 11.4.1.4. Spain 11.4.1.5. U.K. 11.4.1.6. BENELUX 11.4.1.7. Russia 11.4.1.8. Rest of Europe 11.4.2. By Product Type 11.4.3. By Application 11.4.4. By End User 11.5. Market Attractiveness Analysis 11.5.1. By Country 11.5.2. By Product Type 11.5.3. By Application 11.5.4. By End User 12. East Asia Recombinant Protein Market Analysis and Forecast 12.1. Introduction / Key Findings 12.2. Pricing Analysis 12.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017-2021 12.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 - 2032 12.4.1. By Country 12.4.1.1. China 12.4.1.2. Japan 12.4.1.3. South Korea 12.4.2. By Product Type 12.4.3. By Application 12.4.4. By End User 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Product Type 12.5.3. By Application 12.5.4. By End User 13. South Asia & ASEAN Recombinant Protein Market Analysis and Forecast 13.1. Introduction / Key Findings 13.2. Pricing Analysis 13.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017-2021 13.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 - 2032 13.4.1. By Country 13.4.1.1. India 13.4.1.2. Thailand 13.4.1.3. Indonesia 13.4.1.4. Malaysia 13.4.1.5. Rest of South Asia & ASEAN 13.4.2. By Product Type 13.4.3. By Application 13.4.4. By End User 14. Oceania Recombinant Protein Market Analysis and Forecast 14.1. Introduction / Key Findings 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017-2021 14.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 - 2032 14.4.1. By Country 14.4.1.1. Australia 14.4.1.2. New Zealand 14.4.2. Rest of South Asia & Oceania 14.4.3. By Product Type 14.4.4. By Application 14.4.5. By End User 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Product Type 14.5.3. By Application 14.5.4. By End User 15. Middle East & Africa Recombinant Protein Market Analysis and Forecast 15.1. Introduction / Key Findings 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017-2021 15.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 - 2032 15.4.1. By Country 15.4.1.1. GCC Countries 15.4.1.2. South Africa 15.4.1.3. Northern Africa 15.4.1.4. Turkey 15.4.1.5. Rest of Middle East & Africa 15.4.2. By Product Type 15.4.3. By Application 15.4.4. By End User 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Product Type 15.5.3. By Application 15.5.4. By End User 16. Country-level Recombinant Protein Market Analysis and Forecast 16.1. Introduction / Key Findings 16.1.1. Market Value Proportion Analysis, By Key Countries 16.1.2. Global Vs. Country Growth Comparison 16.2. US Recombinant Protein Market Analysis 16.2.1. Value Proportion Analysis by Market Taxonomy 16.2.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.2.2.1. By Product Type 16.2.2.2. By Application 16.2.2.3. By End User 16.3. Canada Recombinant Protein Market Analysis 16.3.1. Value Proportion Analysis by Market Taxonomy 16.3.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.3.2.1. By Product Type 16.3.2.2. By Application 16.3.2.3. By End User 16.4. Brazil Recombinant Protein Market Analysis 16.4.1. Value Proportion Analysis by Market Taxonomy 16.4.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.4.2.1. By Product Type 16.4.2.2. By Application 16.4.2.3. By End User 16.5. Mexico Recombinant Protein Market Analysis 16.5.1. Value Proportion Analysis by Market Taxonomy 16.5.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.5.2.1. By Product Type 16.5.2.2. By Application 16.5.2.3. By End User 16.6. Argentina Recombinant Protein Market Analysis 16.6.1. Value Proportion Analysis by Market Taxonomy 16.6.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.6.2.1. By Product Type 16.6.2.2. By Application 16.6.2.3. By End User 16.7. Germany Recombinant Protein Market Analysis 16.7.1. Value Proportion Analysis by Market Taxonomy 16.7.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.7.2.1. By Product Type 16.7.2.2. By Application 16.7.2.3. By End User 16.8. France Recombinant Protein Market Analysis 16.8.1. Value Proportion Analysis by Market Taxonomy 16.8.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.8.2.1. By Product Type 16.8.2.2. By Application 16.8.2.3. By End User 16.9. Italy Recombinant Protein Market Analysis 16.9.1. Value Proportion Analysis by Market Taxonomy 16.9.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.9.2.1. By Product Type 16.9.2.2. By Application 16.9.2.3. By End User 16.10. Spain Recombinant Protein Market Analysis 16.10.1. Value Proportion Analysis by Market Taxonomy 16.10.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.10.2.1. By Product Type 16.10.2.2. By Application 16.10.2.3. By End User 16.11. BENELUX Recombinant Protein Market Analysis 16.11.1. Value Proportion Analysis by Market Taxonomy 16.11.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.11.2.1. By Product Type 16.11.2.2. By Application 16.11.2.3. By End User 16.12. Russia Recombinant Protein Market Analysis 16.12.1. Value Proportion Analysis by Market Taxonomy 16.12.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.12.2.1. By Product Type 16.12.2.2. By Application 16.12.2.3. By End User 16.13. U.K. Recombinant Protein Market Analysis 16.13.1. Value Proportion Analysis by Market Taxonomy 16.13.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.13.2.1. By Product Type 16.13.2.2. By Application 16.13.2.3. By End User 16.14. China Recombinant Protein Market Analysis 16.14.1. Value Proportion Analysis by Market Taxonomy 16.14.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.14.2.1. By Product Type 16.14.2.2. By Application 16.14.2.3. By End User 16.15. Japan Recombinant Protein Market Analysis 16.15.1. Value Proportion Analysis by Market Taxonomy 16.15.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.15.2.1. By Product Type 16.15.2.2. By Application 16.15.2.3. By End User 16.16. South Korea Recombinant Protein Market Analysis 16.16.1. Value Proportion Analysis by Market Taxonomy 16.16.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.16.2.1. By Product Type 16.16.2.2. By Application 16.16.2.3. By End User 16.17. India Recombinant Protein Market Analysis 16.17.1. Value Proportion Analysis by Market Taxonomy 16.17.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.17.2.1. By Product Type 16.17.2.2. By Application 16.17.2.3. By End User 16.18. Thailand Recombinant Protein Market Analysis 16.18.1. Value Proportion Analysis by Market Taxonomy 16.18.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.18.2.1. By Product Type 16.18.2.2. By Application 16.18.2.3. By End User 16.19. Indonesia Recombinant Protein Market Analysis 16.19.1. Value Proportion Analysis by Market Taxonomy 16.19.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.19.2.1. By Product Type 16.19.2.2. By Application 16.19.2.3. By End User 16.20. Malaysia Recombinant Protein Market Analysis 16.20.1. Value Proportion Analysis by Market Taxonomy 16.20.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.20.2.1. By Product Type 16.20.2.2. By Application 16.20.2.3. By End User 16.21. Rest of South Asia & ASEAN Countries Recombinant Protein Market Analysis 16.21.1. Value Proportion Analysis by Market Taxonomy 16.21.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.21.2.1. By Product Type 16.21.2.2. By Application 16.21.2.3. By End User 16.22. Australia Recombinant Protein Market Analysis 16.22.1. Value Proportion Analysis by Market Taxonomy 16.22.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.22.2.1. By Product Type 16.22.2.2. By Application 16.22.2.3. By End User 16.23. New Zealand Recombinant Protein Market Analysis 16.23.1. Value Proportion Analysis by Market Taxonomy 16.23.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.23.2.1. By Product Type 16.23.2.2. By Application 16.23.2.3. By End User 16.24. GCC Countries Recombinant Protein Market Analysis 16.24.1. Value Proportion Analysis by Market Taxonomy 16.24.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.24.2.1. By Product Type 16.24.2.2. By Application 16.24.2.3. By End User 16.25. Turkey Recombinant Protein Market Analysis 16.25.1. Value Proportion Analysis by Market Taxonomy 16.25.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.25.2.1. By Product Type 16.25.2.2. By Application 16.25.2.3. By End User 16.26. Northern Africa Recombinant Protein Market Analysis 16.26.1. Value Proportion Analysis by Market Taxonomy 16.26.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.26.2.1. By Product Type 16.26.2.2. By Application 16.26.2.3. By End User 16.27. South Africa Recombinant Protein Market Analysis 16.27.1. Value Proportion Analysis by Market Taxonomy 16.27.2. Value (US$ Million) Analysis and Forecast by Market Taxonomy, 2017-2032 16.27.2.1. By Product Type 16.27.2.2. By Application 16.27.2.3. By End User 17. Recombinant Protein Market Structure Analysis 17.1. Market Analysis by Tier of Companies 17.2. Market Concentration of Players 17.3. Market Share Analysis of Top Players 17.4. Market Presence Analysis 18. Recombinant Protein Competition Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking of Products 18.3. Competition Deep Dive: Recombinant Protein 18.3.1. Hologic 18.3.1.1. Overview 18.3.1.2. Product Portfolio 18.3.1.3. Key Financials 18.3.1.4. End User Footprint 18.3.1.5. SWOT Analysis 18.3.1.6. Key Developments 18.3.1.7. Strategy Overview 18.3.2. Care Wise Medical Products (LabLogic Systems, Inc) 18.3.2.1. Overview 18.3.2.2. Product Portfolio 18.3.2.3. Key Financials 18.3.2.4. End User Footprint 18.3.2.5. SWOT Analysis 18.3.2.6. Key Developments 18.3.2.7. Strategy Overview 18.3.3. Devicor Medical Products, Inc. 18.3.3.1. Overview 18.3.3.2. Product Portfolio 18.3.3.3. Key Financials 18.3.3.4. End User Footprint 18.3.3.5. SWOT Analysis 18.3.3.6. Key Developments 18.3.3.7. Strategy Overview 18.3.4. Intramedical Imaging 18.3.4.1. Overview 18.3.4.2. Product Portfolio 18.3.4.3. Key Financials 18.3.4.4. End User Footprint 18.3.4.5. SWOT Analysis 18.3.4.6. Key Developments 18.3.4.7. Strategy Overview 18.3.5. Crystal Photonics GmbH 18.3.5.1. Overview 18.3.5.2. Product Portfolio 18.3.5.3. Key Financials 18.3.5.4. End User Footprint 18.3.5.5. SWOT Analysis 18.3.5.6. Key Developments 18.3.5.7. Strategy Overview 18.3.6. BIODEX 18.3.6.1. Overview 18.3.6.2. Product Portfolio 18.3.6.3. Key Financials 18.3.6.4. End User Footprint 18.3.6.5. SWOT Analysis 18.3.6.6. Key Developments 18.3.6.7. Strategy Overview 18.3.7. Oncovision 18.3.7.1. Overview 18.3.7.2. Product Portfolio 18.3.7.3. Key Financials 18.3.7.4. End User Footprint 18.3.7.5. SWOT Analysis 18.3.7.6. Key Developments 18.3.7.7. Strategy Overview 18.3.8. Capintec Inc 18.3.8.1. Overview 18.3.8.2. Product Portfolio 18.3.8.3. Key Financials 18.3.8.4. End User Footprint 18.3.8.5. SWOT Analysis 18.3.8.6. Key Developments 18.3.8.7. Strategy Overview 19. Assumptions & Acronyms Used 20. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Recombinant Protein Market Value (USD Million) and Forecast by Region, 2017-2021
Table 02: Global Recombinant Protein Market Value (USD Million) and Forecast by Region, 2022-2032
Table 03: Global Recombinant Protein Market Value (USD Million) and Forecast by Product Type, 2017-2021
Table 04: Global Recombinant Protein Market Value (USD Million) and Forecast by Product Type, 2022-2032
Table 05: Global Recombinant Protein Market Value (USD Million) and Forecast by Application, 2017-2021
Table 06: Global Recombinant Protein Market Value (USD Million) and Forecast by Application, 2022-2032
Table 07: Global Recombinant Protein Market Value (USD Million) and Forecast by End User, 2017-2021
Table 08: Global Recombinant Protein Market Value (USD Million) and Forecast by End User, 2022-2032
Table 09: North America Recombinant Protein Market Value (USD Million) and Forecast by Country, 2017-2021
Table 10: North America Recombinant Protein Market Value (USD Million) and Forecast by Country, 2022-2032
Table 11: North America Recombinant Protein Market Value (USD Million) and Forecast by Product Type, 2017-2021
Table 12: North America Recombinant Protein Market Value (USD Million) and Forecast by Product Type, 2022-2032
Table 13: North America Recombinant Protein Market Value (USD Million) and Forecast by Application, 2017-2021
Table 14: North America Recombinant Protein Market Value (USD Million) and Forecast by Application, 2022-2032
Table 15: North America Recombinant Protein Market Value (USD Million) and Forecast by End User, 2017-2021
Table 16: North America Recombinant Protein Market Value (USD Million) and Forecast by End User, 2022-2032
Table 17: Latin America Recombinant Protein Market Value (USD Million) and Forecast by Country, 2017-2021
Table 18: Latin America Recombinant Protein Market Value (USD Million) and Forecast by Country, 2022-2032
Table 19: Latin America Recombinant Protein Market Value (USD Million) and Forecast by Product Type, 2017-2021
Table 20: Latin America Recombinant Protein Market Value (USD Million) and Forecast by Product Type, 2022-2032
Table 21: Latin America Recombinant Protein Market Value (USD Million) and Forecast by Application, 2017-2021
Table 22: Latin America Recombinant Protein Market Value (USD Million) and Forecast by Application, 2022-2032
Table 23: Latin America Recombinant Protein Market Value (USD Million) and Forecast by End User, 2017-2021
Table 24: Latin America Recombinant Protein Market Value (USD Million) and Forecast by End User, 2022-2032
Table 25: Europe Recombinant Protein Market Value (USD Million) and Forecast by Country, 2017-2021
Table 26: Europe Recombinant Protein Market Value (USD Million) and Forecast by Country, 2022-2032
Table 27: Europe Recombinant Protein Market Value (USD Million) and Forecast by Product Type, 2017-2021
Table 28: Europe Recombinant Protein Market Value (USD Million) and Forecast by Product Type, 2022-2032
Table 29: Europe Recombinant Protein Market Value (USD Million) and Forecast by Application, 2017-2021
Table 30: Europe Recombinant Protein Market Value (USD Million) and Forecast by Application, 2022-2032
Table 31: Europe Recombinant Protein Market Value (USD Million) and Forecast by End User, 2017-2021
Table 32: Europe Recombinant Protein Market Value (USD Million) and Forecast by End User, 2022-2032
Table 33: East Asia Recombinant Protein Market Value (USD Million) and Forecast by Country, 2017-2021
Table 34: East Asia Recombinant Protein Market Value (USD Million) and Forecast by Country, 2022-2032
Table 35: East Asia Recombinant Protein Market Value (USD Million) and Forecast by Product Type, 2017-2021
Table 36: East Asia Recombinant Protein Market Value (USD Million) and Forecast by Product Type, 2022-2032
Table 37: East Asia Recombinant Protein Market Value (USD Million) and Forecast by Application, 2017-2021
Table 38: East Asia Recombinant Protein Market Value (USD Million) and Forecast by Application, 2022-2032
Table 39: East Asia Recombinant Protein Market Value (USD Million) and Forecast by End User, 2017-2021
Table 40: East Asia Recombinant Protein Market Value (USD Million) and Forecast by End User, 2022-2032
Table 41: South Asia & ASEAN Recombinant Protein Market Value (USD Million) and Forecast by Country, 2017-2021
Table 42: South Asia & ASEAN Recombinant Protein Market Value (USD Million) and Forecast by Country, 2022-2032
Table 43: South Asia & ASEAN Recombinant Protein Market Value (USD Million) and Forecast by Product Type, 2017-2021
Table 44: South Asia & ASEAN Recombinant Protein Market Value (USD Million) and Forecast by Product Type, 2022-2032
Table 45: South Asia & ASEAN Recombinant Protein Market Value (USD Million) and Forecast by Application, 2017-2021
Table 46: South Asia & ASEAN Recombinant Protein Market Value (USD Million) and Forecast by Application, 2022-2032
Table 47: South Asia & ASEAN Recombinant Protein Market Value (USD Million) and Forecast by End User, 2017-2021
Table 48: South Asia & ASEAN Recombinant Protein Market Value (USD Million) and Forecast by End User, 2022-2032
Table 49: Oceania Recombinant Protein Market Value (USD Million) and Forecast by Country, 2017-2021
Table 50: Oceania Recombinant Protein Market Value (USD Million) and Forecast by Country, 2022-2032
Table 51: Oceania Recombinant Protein Market Value (USD Million) and Forecast by Product Type, 2017-2021
Table 52: Oceania Recombinant Protein Market Value (USD Million) and Forecast by Product Type, 2022-2032
Table 53: Oceania Recombinant Protein Market Value (USD Million) and Forecast by Application, 2017-2021
Table 54: Oceania Recombinant Protein Market Value (USD Million) and Forecast by Application, 2022-2032
Table 55: Oceania Recombinant Protein Market Value (USD Million) and Forecast by End User, 2017-2021
Table 56: Oceania Recombinant Protein Market Value (USD Million) and Forecast by End User, 2022-2032
Table 57: MEA Recombinant Protein Market Value (USD Million) and Forecast by Country, 2017-2021
Table 58: MEA Recombinant Protein Market Value (USD Million) and Forecast by Country, 2022-2032
Table 59: MEA Recombinant Protein Market Value (USD Million) and Forecast by Product Type, 2017-2021
Table 60: MEA Recombinant Protein Market Value (USD Million) and Forecast by Product Type, 2022-2032
Table 61: MEA Recombinant Protein Market Value (USD Million) and Forecast by Application, 2017-2021
Table 62: MEA Recombinant Protein Market Value (USD Million) and Forecast by Application, 2022-2032
Table 63: MEA Recombinant Protein Market Value (USD Million) and Forecast by End User, 2017-2021
Table 64: MEA Recombinant Protein Market Value (USD Million) and Forecast by End User, 2022-2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Recombinant Protein Market Value (USD Million) Forecast, 2022-2032
Figure 02: Global Recombinant Protein Market Absolute $ Opportunity (USD Million), 2022-2032
Figure 03: Global Recombinant Protein Market Value (USD Million) by Region, 2022 & 2032
Figure 4: Global Recombinant Protein Market Y-o-Y Growth Rate by Region, 2022-2032
Figure 05: Global Recombinant Protein Market Value (USD Million) by Product Type, 2022 & 2032
Figure 06: Global Recombinant Protein Market Y-o-Y Growth Rate by Product Type, 2022-2032
Figure 07: Global Recombinant Protein Market Value (USD Million) by Application, 2022 & 2032
Figure 08: Global Recombinant Protein Market Y-o-Y Growth Rate by Application, 2022-2032
Figure 09: Global Recombinant Protein Market Value (USD Million) by End User, 2022 & 2032
Figure 10: Global Recombinant Protein Market Y-o-Y Growth Rate by End User, 2022-2032
Figure 11: North America Recombinant Protein Market Value (USD Million) Forecast, 2022-2032
Figure 12: North America Recombinant Protein Market Absolute $ Opportunity (USD Million), 2022-2032
Figure 13: North America Recombinant Protein Market Value (USD Million) by Country, 2022 & 2032
Figure 14: North America Recombinant Protein Market Y-o-Y Growth Rate by Country, 2022-2032
Figure 15: North America Recombinant Protein Market Value (USD Million) by Product Type, 2022 & 2032
Figure 16: North America Recombinant Protein Market Y-o-Y Growth Rate by Product Type, 2022-2032
Figure 17: North America Recombinant Protein Market Value (USD Million) by Application, 2022 & 2032
Figure 18: North America Recombinant Protein Market Y-o-Y Growth Rate by Application, 2022-2032
Figure 19: North America Recombinant Protein Market Value (USD Million) by End User, 2022 & 2032
Figure 20: North America Recombinant Protein Market Y-o-Y Growth Rate by End User, 2022-2032
Figure 21: North America Recombinant Protein Market Attractiveness Analysis by Country, 2022-2032
Figure 22: North America Recombinant Protein Market Attractiveness Analysis by Product Type, 2022-2032
Figure 23: North America Recombinant Protein Market Attractiveness Analysis by Application, 2022-2032
Figure 24: North America Recombinant Protein Market Attractiveness Analysis by End User, 2022-2032
Figure 25: Latin America Recombinant Protein Market Value (USD Million) Forecast, 2022-2032
Figure 26: Latin America Recombinant Protein Market Absolute $ Opportunity (USD Million), 2022-2032
Figure 27: Latin America Recombinant Protein Market Value (USD Million) by Country, 2022 & 2032
Figure 28: Latin America Recombinant Protein Market Y-o-Y Growth Rate by Country, 2022-2032
Figure 29: Latin America Recombinant Protein Market Value (USD Million) by Product Type, 2022 & 2032
Figure 30: Latin America Recombinant Protein Market Y-o-Y Growth Rate by Product Type, 2022-2032
Figure 31: Latin America Recombinant Protein Market Value (USD Million) by Application, 2022 & 2032
Figure 32: Latin America Recombinant Protein Market Y-o-Y Growth Rate by Application, 2022-2032
Figure 33: Latin America Recombinant Protein Market Value (USD Million) by End User, 2022 & 2032
Figure 34: Latin America Recombinant Protein Market Y-o-Y Growth Rate by End User, 2022-2032
Figure 35: Latin America Recombinant Protein Market Attractiveness Analysis by Country, 2022-2032
Figure 36: Latin America Recombinant Protein Market Attractiveness Analysis by Product Type, 2022-2032
Figure 37: Latin America Recombinant Protein Market Attractiveness Analysis by Application, 2022-2032
Figure 38: Latin America Recombinant Protein Market Attractiveness Analysis by End User, 2022-2032
Figure 39: Europe Recombinant Protein Market Value (USD Million) Forecast, 2022-2032
Figure 40: Europe Recombinant Protein Market Absolute $ Opportunity (USD Million), 2022-2032
Figure 41: Europe Recombinant Protein Market Value (USD Million) by Country, 2022 & 2032
Figure 42: Europe Recombinant Protein Market Y-o-Y Growth Rate by Country, 2022-2032
Figure 43: Europe Recombinant Protein Market Value (USD Million) by Product Type, 2022 & 2032
Figure 44: Europe Recombinant Protein Market Y-o-Y Growth Rate by Product Type, 2022-2032
Figure 45: Europe Recombinant Protein Market Value (USD Million) by Application, 2022 & 2032
Figure 46: Europe Recombinant Protein Market Y-o-Y Growth Rate by Application, 2022-2032
Figure 47: Europe Recombinant Protein Market Value (USD Million) by End User, 2022 & 2032
Figure 48: Europe Recombinant Protein Market Y-o-Y Growth Rate by End User, 2022-2032
Figure 49: Europe Recombinant Protein Market Attractiveness Analysis by Country, 2022-2032
Figure 50: Europe Recombinant Protein Market Attractiveness Analysis by Product Type, 2022-2032
Figure 51: Europe Recombinant Protein Market Attractiveness Analysis by Application, 2022-2032
Figure 52: Europe Recombinant Protein Market Attractiveness Analysis by End User, 2022-2032
Figure 53: East Asia Recombinant Protein Market Value (USD Million) Forecast, 2022-2032
Figure 54: East Asia Recombinant Protein Market Absolute $ Opportunity (USD Million), 2022-2032
Figure 55: East Asia Recombinant Protein Market Value (USD Million) by Country, 2022 & 2032
Figure 56: East Asia Recombinant Protein Market Y-o-Y Growth Rate by Country, 2022-2032
Figure 57: East Asia Recombinant Protein Market Value (USD Million) by Product Type, 2022 & 2032
Figure 58: East Asia Recombinant Protein Market Y-o-Y Growth Rate by Product Type, 2022-2032
Figure 59: East Asia Recombinant Protein Market Value (USD Million) by Application, 2022 & 2032
Figure 60: East Asia Recombinant Protein Market Y-o-Y Growth Rate by Application, 2022-2032
Figure 61: East Asia Recombinant Protein Market Value (USD Million) by End User, 2022 & 2032
Figure 62: East Asia Recombinant Protein Market Y-o-Y Growth Rate by End User, 2022-2032
Figure 63: East Asia Recombinant Protein Market Attractiveness Analysis by Country, 2022-2032
Figure 64: East Asia Recombinant Protein Market Attractiveness Analysis by Product Type, 2022-2032
Figure 65: East Asia Recombinant Protein Market Attractiveness Analysis by Application, 2022-2032
Figure 66: East Asia Recombinant Protein Market Attractiveness Analysis by End User, 2022-2032
Figure 67: South Asia & ASEAN Recombinant Protein Market Value (USD Million) Forecast, 2022-2032
Figure 68: South Asia & ASEAN Recombinant Protein Market Absolute $ Opportunity (USD Million), 2022-2032
Figure 69: South Asia & ASEAN Recombinant Protein Market Value (USD Million) by Country, 2022 & 2032
Figure 70: South Asia & ASEAN Recombinant Protein Market Y-o-Y Growth Rate by Country, 2022-2032
Figure 71: South Asia & ASEAN Recombinant Protein Market Value (USD Million) by Product Type, 2022 & 2032
Figure 72: South Asia & ASEAN Recombinant Protein Market Y-o-Y Growth Rate by Product Type, 2022-2032
Figure 73: South Asia & ASEAN Recombinant Protein Market Value (USD Million) by Application, 2022 & 2032
Figure 74: South Asia & ASEAN Recombinant Protein Market Y-o-Y Growth Rate by Application, 2022-2032
Figure 75: South Asia & ASEAN Recombinant Protein Market Value (USD Million) by End User, 2022 & 2032
Figure 76: South Asia & ASEAN Recombinant Protein Market Y-o-Y Growth Rate by End User, 2022-2032
Figure 77: South Asia & ASEAN Recombinant Protein Market Attractiveness Analysis by Country, 2022-2032
Figure 78: South Asia & ASEAN Recombinant Protein Market Attractiveness Analysis by Product Type, 2022-2032
Figure 79: South Asia & ASEAN Recombinant Protein Market Attractiveness Analysis by Application, 2022-2032
Figure 80: South Asia & ASEAN Recombinant Protein Market Attractiveness Analysis by End User, 2022-2032
Figure 81: Oceania Recombinant Protein Market Value (USD Million) Forecast, 2022-2032
Figure 82: Oceania Recombinant Protein Market Absolute $ Opportunity (USD Million), 2022-2032
Figure 83: Oceania Recombinant Protein Market Value (USD Million) by Country, 2022 & 2032
Figure 84: Oceania Recombinant Protein Market Y-o-Y Growth Rate by Country, 2022-2032
Figure 85: Oceania Recombinant Protein Market Value (USD Million) by Product Type, 2022 & 2032
Figure 86: Oceania Recombinant Protein Market Y-o-Y Growth Rate by Product Type, 2022-2032
Figure 87: Oceania Recombinant Protein Market Value (USD Million) by Application, 2022 & 2032
Figure 88: Oceania Recombinant Protein Market Y-o-Y Growth Rate by Application, 2022-2032
Figure 89: Oceania Recombinant Protein Market Value (USD Million) by End User, 2022 & 2032
Figure 90: Oceania Recombinant Protein Market Y-o-Y Growth Rate by End User, 2022-2032
Figure 91: Oceania Recombinant Protein Market Attractiveness Analysis by Country, 2022-2032
Figure 92: Oceania Recombinant Protein Market Attractiveness Analysis by Product Type, 2022-2032
Figure 93: Oceania Recombinant Protein Market Attractiveness Analysis by Application, 2022-2032
Figure 94: Oceania Recombinant Protein Market Attractiveness Analysis by End User, 2022-2032
Figure 95: MEA Recombinant Protein Market Value (USD Million) Forecast, 2022-2032
Figure 96: MEA Recombinant Protein Market Absolute $ Opportunity (USD Million), 2022-2032
Figure 97: MEA Recombinant Protein Market Value (USD Million) by Country, 2022 & 2032
Figure 98: MEA Recombinant Protein Market Y-o-Y Growth Rate by Country, 2022-2032
Figure 99: MEA Recombinant Protein Market Value (USD Million) by Product Type, 2022 & 2032
Figure 100: MEA Recombinant Protein Market Y-o-Y Growth Rate by Product Type, 2022-2032
Figure 101: MEA Recombinant Protein Market Value (USD Million) by Application, 2022 & 2032
Figure 102: MEA Recombinant Protein Market Y-o-Y Growth Rate by Application, 2022-2032
Figure 103: MEA Recombinant Protein Market Value (USD Million) by End User, 2022 & 2032
Figure 104: MEA Recombinant Protein Market Y-o-Y Growth Rate by End User, 2022-2032
Figure 105: MEA Recombinant Protein Market Attractiveness Analysis by Country, 2022-2032
Figure 106: MEA Recombinant Protein Market Attractiveness Analysis by Product Type, 2022-2032
Figure 107: MEA Recombinant Protein Market Attractiveness Analysis by Application, 2022-2032
Figure 108: MEA Recombinant Protein Market Attractiveness Analysis by End User, 2022-2032
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the global recombinant protein market size?
The global recombinant protein market is anticipated to be valued at US$ 457.1 million in 2022.
How is the market for recombinant protein expected to fare going forward?
Worldwide demand for recombinant protein is anticipated to reach US$ 719.5 million by 2032-end.
Which regional recombinant protein market accounts for a leading market share?
North America tops the global recombinant protein market will account for 32.7% market share in 2022.
Which product type holds the highest market share?
Growth factors by product type will account for 21.3% share of global sales in 2022.
How did the market perform over the last few years?
During 2017-2021, sales of recombinant protein increased at 4.3% CAGR.
Recombinant Protein Market